Searched for
GAMALEYA RESEARCH INSTITUTE
Cancer cure? Russia commences human trials of revolutionary personalized cancer vaccineRussia's Gamaleya Center, famed for Sputnik V, will initiate human trials for a personalized mRNA melanoma vaccine by late 2025. This innov...- Two doses of Sputnik provide two times higher antibodies against Omicron than Pfizer vaccine: StudyThe study was conducted at the Italian Spallanzani Institute on comparable groups of sera from individuals vaccinated with Sputnik V and Pf...
- Sputnik V protects two times more against Covid than Pfizer's vaccine: StudySputnik V in a statement on Thursday said that as per an independent comparative study conducted by the Spallanzani institute in Italy, its...
- Omicron variant could replace Delta strain globally: Head of Russian Gamaleya InstituteAccording to the Gamaleya institute director, the effectiveness of the Russian Sputnik V vaccine against the Omicron strain will be tested ...
- Sputnik Light produces strong level of antibodies against COVID-19 in early-stage trialsThe vaccine, a single-dose version of the two-dose Sputnik V vaccine unveiled last year, has already entered later phases of studies and is...
- Serum Institute gets DCGI's nod to manufacture Sputnik V in India for test, analysis"The DCGI has granted permission to the Serum Institute to manufacture the Sputnik COVID-19 vaccine in India for examination, test and anal...
- Vaccine vacuum gives birth to a bunch of dubious dealersDistributors in countries such as the Czech Republic, UK and the UAE have been promising state governments delivery of Covid-19 vaccines, e...
- Russia says Sputnik V vaccine does not cause blood clots"A comprehensive analysis of adverse events during clinical trials and over the course of mass vaccinations with the Sputnik V vaccine show...
- Russia repeats 91.4% efficacy rate in new COVID-19 vaccine data: DevelopersThe new results are based on data from 22,714 participants in the trial, and were published after 78 confirmed coronavirus cases were repor...
- Oxford/AstraZeneca in ‘mix-match' COVID-19 vaccine trial with Russia's SputnikThe two sets of experts are to join forces to explore if a combination of the two jabs, both using a benign virus called adenovirus, could ...
- AstraZeneca to test combining COVID-19 vaccine with Russian shotThe developers of Sputnik V suggested on Twitter last month that AstraZeneca try the combination.
- How common cold viruses are being used in vaccines from Russia, ChinaSome researchers believe the strong immune response that caused problems with gene therapy makes these vectors well suited to vaccines, whe...
- Russia looking for partnership with India for producing COVID-19 vaccine Sputnik: RDIF CEOSputnik V has been developed by the Gamaleya Research Institute of Epidemiology and Microbiology, along with the RDIF. The vaccine has not ...
- Safety, efficacy main concerns with Russia's COVID-19 vaccine: Nobel laureate Peter DohertySputnik V has been developed by the Gamaleya Research Institute of Epidemiology and Microbiology along with the Russian Direct Investment F...
- Indian pharma producers show great interest in Covid-19 vaccine Sputnik V: Russian sovereign wealth fundThe RDIF has funded research and production of Sputnik V, the world’s first approved coronavirus vaccine, developed by the Moscow-based Gam...
- Russia not world's first to develop coronavirus vaccine: Kiran Mazumdar-ShawThe world has not seen any data on Phase 1 or 2 clinical trials conducted by Moscow-based Gamaleya Research Institute, the Executive Chairp...
- India among 20 countries interested in obtaining Covid-19 vaccine from RussiaRDIF has seen strong global interest in the vaccine and plans to conduct Phase 3 clinical trials in different countries, including Saudi Ar...
- Russia plans to register the world's first coronavirus vaccine on August 12"The vaccine developed by the Gamaleya centre will be registered on August 12. At the moment, the last, third, stage is underway. The trial...
- Russia aims to launch mass production of coronavirus vaccine doses by 2021The country is pushing ahead with several vaccine prototypes and one trialled by the Gamaleya institute in Moscow has reached advanced stag...
- Russia plans mass vaccination against coronavirus from October, health workers first in lineA source told Reuters this week that Russia's first potential COVID-19 vaccine, developed by a state research facility, would secure local ...
Load More
